Hemant Surgical Industries (BOM:543916) Total Liabilities: ₹1,366 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543916 Hemant Surgical Industries Ltd BOM:543916
80 GF Score
Price ₹356.25
GF Value ₹335.02
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Hemant Surgical Industries Total Liabilities?

Hemant Surgical Industries BOM:543916 -0.97% 80 Total Liabilities is ₹1,366 Mil as of Mar. 2026. GuruFocus rates BOM:543916 with a GF Score™ of 80/100 and a GF Value™ of ₹335.02 (Fairly Valued). The stock has 3 warning signs investors should review.

Hemant Surgical Industries's Total Liabilities for the quarter that ended in Mar. 2026 was ₹1,366 Mil.

Hemant Surgical Industries's quarterly Total Liabilities increased from Mar. 2025 (₹851.36 Mil) to Sep. 2025 (₹916.91 Mil) and increased from Sep. 2025 (₹916.91 Mil) to Mar. 2026 (₹1,366.17 Mil).

Hemant Surgical Industries's annual Total Liabilities increased from Mar. 2024 (₹417.79 Mil) to Mar. 2025 (₹851.36 Mil) and increased from Mar. 2025 (₹851.36 Mil) to Mar. 2026 (₹1,366.17 Mil).

Hemant Surgical Industries Total Liabilities Historical Data

* Premium members only.

The historical data trend for Hemant Surgical Industries's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemant Surgical Industries Total Liabilities Chart

Hemant Surgical Industries Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial 412.28 413.36 417.79 851.36 1,366.17

Hemant Surgical Industries Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 417.79 579.02 851.36 916.91 1,366.17
BOM:543916
80GF Score
Hemant Surgical Industries Ltd BOM:543916
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hemant Surgical Industries Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hemant Surgical Industries's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1330.936+(28.836+6.3980000000002
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1,366

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=2742.611-1376.441
=1,366

Hemant Surgical Industries's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1330.936+(28.836+6.3980000000002
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1,366

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=2742.611-1376.441
=1,366

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹1,366 Mil mean?
Hemant Surgical Industries (BOM:543916) has a Total Liabilities of ₹1,366 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Hemant Surgical Industries and its competitors.
Is Hemant Surgical Industries' Total Liabilities too high?
Hemant Surgical Industries' current Total Liabilities is ₹1,366 Mil. Overall, Hemant Surgical Industries has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hemant Surgical Industries' Total Liabilities compare to ABT and SYK?
Hemant Surgical Industries' Total Liabilities of ₹1,366 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Hemant Surgical Industries and its competitors. Hemant Surgical Industries's current Total Liabilities is ₹1,366 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemant Surgical Industries stock overvalued right now?
Based on GuruFocus' analysis, Hemant Surgical Industries (BOM:543916) is currently considered Fairly Valued. The stock's GF Value™ is ₹335.02, compared to a current price of ₹356.25 — trading 6.3% above its estimated fair value. The current Total Liabilities is ₹1,366 Mil. Hemant Surgical Industries' overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Hemant Surgical Industries (BOM:543916), the current Total Liabilities is ₹1,366 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hemant Surgical Industries (BOM:543916) Overvalued in 2026?

Based on GuruFocus' analysis, Hemant Surgical Industries stock appears to be overvalued. The current stock price of ₹356.25 is trading 6.3% above its estimated GF Value™ of ₹335.02. GuruFocus considers Hemant Surgical Industries to be Fairly Valued.

Key valuation signals for BOM:543916:

  • Total Liabilities: ₹1,366 Mil
  • GF Value™: ₹335.02 vs. price of ₹356.25 (6.3% above fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the BOM:543916 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hemant Surgical Industries Business Description

Address J.S.D. Road, 502, 5th Floor, Ecstasy Business Park, Co-Op Society Limited, Mulund West, Mumbai, MH, IND, 400 080
Hemant Surgical Industries Ltd is engaged in Importing, manufacturing, and marketing quality surgical and Pharmaceutical Products at an economical price. Its product offerings cover a wide spectrum of equipment and disposables required for (i) Renal Care, (ii) Cardiovascular Disease, (iii) Respiratory Disease, (iv) Critical Care and Radiology, and (v) Surgical disposables. Its products include JMS Meditape, JMS Infusion Set, JMS Scalp Vein Set, Ventilators, ECG Machines, and others.
80GF Score

Get the complete analysis for BOM:543916

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹356.25
Price
₹335.02
GF Value